申请人:Tanabe Seiyaku Co., Ltd.
公开号:US05831091A1
公开(公告)日:1998-11-03
An N-\x9b2-(1-hydroxyethyl)-3-oxopropyl!amine compound of the formula \x9bIII!: ##STR1## wherein Ring B represents a benzene ring which may be substituted; W represents oxygen atom or sulfur atom; Y represents oxygen atom, sulfur atom or N R.sup.0, R.sup.0 represents hydrogen atom or a substituent; Z represents a substituted methylene group which contains at least one chiral center; R.sup.5 represents an aralkyloxycarbonyl group or an alkoxycarbonyl group; R.sup.6 represents hydrogen atom, an aralkyl group, an acyloxy group, a tri-substituted silyloxy group or an alkoxy group; or both of R.sup.5 and R.sup.6 bond at their termini and combine with the adjacent nitrogen atom to form phthalimido group, and a process thereof are disclosed. Said compound \x9bIII! is useful as a starting compound of .beta.-lactam antibacterial agents.
公式为III的N-\x9b2-(1-羟乙基)-3-氧代戊二酰基胺化合物:##STR1## 其中,环B代表可能被取代的苯环;W代表氧原子或硫原子;Y代表氧原子、硫原子或N R.sup.0,R.sup.0代表氢原子或取代基;Z代表含有至少一个手性中心的取代亚甲基基团;R.sup.5代表芳基烷氧羰基基团或烷氧羰基基团;R.sup.6代表氢原子、芳基烷基基团、酰氧基、三取代硅氧基或烷氧基;或者R.sup.5和R.sup.6在其末端结合并与相邻的氮原子结合形成邻苯二甲酰亚胺基团;公开了其制备过程。所述的化合物\x9bIII!可用作β-内酰胺类抗菌药物的起始化合物。